A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain (opens ClinicalTrials.gov)
- Sponsor
- Eli Lilly and Company
- Enrolment
- 150
- Started
- 2026-02-16
- Last update
- 2026-11-04
Conditions: Diabetic Peripheral Neuropathic Pain
Interventions: LY4065967, Placebo